These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12702508)

  • 1. Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells.
    Matussek A; Lauber J; Bergau A; Hansen W; Rohde M; Dittmar KE; Gunzer M; Mengel M; Gatzlaff P; Hartmann M; Buer J; Gunzer F
    Blood; 2003 Aug; 102(4):1323-32. PubMed ID: 12702508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin.
    Louise CB; Kaye SA; Boyd B; Lingwood CA; Obrig TG
    Infect Immun; 1995 Jul; 63(7):2766-9. PubMed ID: 7790096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Escherichia coli Shiga toxin.
    Nakao H; Takeda T
    J Nat Toxins; 2000 Aug; 9(3):299-313. PubMed ID: 10994531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shiga toxin-associated hemolytic uremic syndrome: pathophysiology of endothelial dysfunction.
    Zoja C; Buelli S; Morigi M
    Pediatr Nephrol; 2010 Nov; 25(11):2231-40. PubMed ID: 20424866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of virulence factors in enterohemorrhagic Escherichia coli (EHEC)--associated hemolytic-uremic syndrome.
    Karch H
    Semin Thromb Hemost; 2001 Jun; 27(3):207-13. PubMed ID: 11446654
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal apoptosis and inflammatory responses in the central nervous system of a rabbit treated with Shiga toxin-2.
    Takahashi K; Funata N; Ikuta F; Sato S
    J Neuroinflammation; 2008 Mar; 5():11. PubMed ID: 18355415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction by sphingomyelinase of shiga toxin receptor and shiga toxin 2 sensitivity in human microvascular endothelial cells.
    Obrig TG; Seaner RM; Bentz M; Lingwood CA; Boyd B; Smith A; Narrow W
    Infect Immun; 2003 Feb; 71(2):845-9. PubMed ID: 12540565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shiga Toxins: An Update on Host Factors and Biomedical Applications.
    Liu Y; Tian S; Thaker H; Dong M
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33803852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shiga toxins, glycosphingolipid diversity, and endothelial cell injury.
    Müthing J; Schweppe CH; Karch H; Friedrich AW
    Thromb Haemost; 2009 Feb; 101(2):252-64. PubMed ID: 19190807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenic functions and diagnostic utility of cytokines/chemokines in EHEC-HUS.
    Shimizu M
    Pediatr Int; 2020 Mar; 62(3):308-315. PubMed ID: 31742829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome.
    van de Kar NC; Monnens LA; Karmali MA; van Hinsbergh VW
    Blood; 1992 Dec; 80(11):2755-64. PubMed ID: 1333300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shiga toxin-associated hemolytic uremic syndrome: interleukin-1 beta enhancement of Shiga toxin cytotoxicity toward human vascular endothelial cells in vitro.
    Kaye SA; Louise CB; Boyd B; Lingwood CA; Obrig TG
    Infect Immun; 1993 Sep; 61(9):3886-91. PubMed ID: 8359910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gnotobiotic piglets develop thrombotic microangiopathy after oral infection with enterohemorrhagic Escherichia coli.
    Gunzer F; Hennig-Pauka I; Waldmann KH; Sandhoff R; Gröne HJ; Kreipe HH; Matussek A; Mengel M
    Am J Clin Pathol; 2002 Sep; 118(3):364-75. PubMed ID: 12219778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental In Vivo Models of Bacterial Shiga Toxin-Associated Hemolytic Uremic Syndrome.
    Jeong YJ; Park SK; Yoon SJ; Park YJ; Lee MS
    J Microbiol Biotechnol; 2018 Sep; 28(9):1413-1425. PubMed ID: 29926707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent Advancements in Technologies to Detect Enterohaemorrhagic
    Kim J; Lee JB; Park J; Koo C; Lee MS
    J Microbiol Biotechnol; 2023 May; 33(5):559-573. PubMed ID: 36859335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facing glycosphingolipid-Shiga toxin interaction: dire straits for endothelial cells of the human vasculature.
    Bauwens A; Betz J; Meisen I; Kemper B; Karch H; Müthing J
    Cell Mol Life Sci; 2013 Feb; 70(3):425-57. PubMed ID: 22766973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-33/ST2 signaling contributes to the severity of hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.
    Yamada S; Shimizu M; Kuroda M; Inoue N; Sugimoto N; Yachie A
    Clin Exp Nephrol; 2019 Apr; 23(4):544-550. PubMed ID: 30467800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shiga toxin-glycosphingolipid interaction: Status quo of research with focus on primary human brain and kidney endothelial cells.
    Legros N; Pohlentz G; Steil D; Müthing J
    Int J Med Microbiol; 2018 Dec; 308(8):1073-1084. PubMed ID: 30224239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor affinity, stability and binding mode of Shiga toxins are determinants of toxicity.
    Shimizu T; Sato T; Kawakami S; Ohta T; Noda M; Hamabata T
    Microb Pathog; 2007; 43(2-3):88-95. PubMed ID: 17532600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shiga toxin 2 reduces complement inhibitor CD59 expression on human renal tubular epithelial and glomerular endothelial cells.
    Ehrlenbach S; Rosales A; Posch W; Wilflingseder D; Hermann M; Brockmeyer J; Karch H; Satchell SC; Würzner R; Orth-Höller D
    Infect Immun; 2013 Aug; 81(8):2678-85. PubMed ID: 23690395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.